Concepedia

Jan Brabender

JB

72

Publications

5.2K

Citations

36

H-Index

2001

Active since

Affiliations

University of Cologne(Current)

University of Southern California

University Hospital Cologne

Heinrich Heine University Düsseldorf

University Hospital of Zurich

Jan Brabender is an author at University of Cologne specializing in medicine, pathology, and cancer research.

Top concepts

Publications per year

2001–2013

72

Publications

72

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

Reginald V. Lord, Jan Brabender, David R. Gandara et al. · PubMed · 2002 · 671 citations

<i>ERCC1</i> and Thymidylate Synthase mRNA Levels Predict Survival for Colorectal Cancer Patients Receiving Combination Oxaliplatin and Fluorouracil Chemotherapy

Yoshinori Shirota, Jan Stoehlmacher, Jan Brabender et al. · Journal of Clinical Oncology · 2001 · 607 citations

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.

Jan Brabender, Kathleen D. Danenberg, Ralf Metzger et al. · PubMed · 2001 · 457 citations

, , +13

Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.

Henning Usadel, Jan Brabender, K. D. Danenberg et al. · PubMed · 2002 · 303 citations

, , +18

Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression.

Kazuyuki Kawakami, Dennis Salonga, Ji Min Park et al. · PubMed · 2001 · 227 citations

Rows per page

1–5 of 72